PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial.
Saved in:
| Title: | PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial. |
|---|---|
| Authors: | Maggie Liu, Si-Yang1 (AUTHOR), Huang, Jie1,2 (AUTHOR), Deng, Jia-Yi1,2 (AUTHOR), Xu, Chong-Rui2 (AUTHOR), Yan, Hong-Hong2,3 (AUTHOR), Yang, Ming-Yi2 (AUTHOR), Li, Yang-Si2 (AUTHOR), Ke, E-E2 (AUTHOR), Zheng, Ming-Ying2 (AUTHOR), Wang, Zhen2 (AUTHOR), Lin, Jia-Xin2 (AUTHOR), Gan, Bin2 (AUTHOR), Zhang, Xu-Chao2 (AUTHOR), Chen, Hua-Jun2 (AUTHOR), Wang, Bin-Chao2 (AUTHOR), Tu, Hai-Yan2 (AUTHOR), Yang, Jin-Ji2 (AUTHOR), Zhong, Wen-Zhao2 (AUTHOR), Li, Yangqiu1,4 (AUTHOR) yangqiuli@hotmail.com, Zhou, Qing1,2,3 (AUTHOR) gzzhouqing@126.com |
| Source: | Science Bulletin. Feb2024, Vol. 69 Issue 4, p535-543. 9p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 175240970 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Maggie+Liu%2C+Si-Yang%22">Maggie Liu, Si-Yang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Jie%22">Huang, Jie</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Deng%2C+Jia-Yi%22">Deng, Jia-Yi</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Chong-Rui%22">Xu, Chong-Rui</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yan%2C+Hong-Hong%22">Yan, Hong-Hong</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+Ming-Yi%22">Yang, Ming-Yi</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Yang-Si%22">Li, Yang-Si</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ke%2C+E-E%22">Ke, E-E</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zheng%2C+Ming-Ying%22">Zheng, Ming-Ying</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Zhen%22">Wang, Zhen</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lin%2C+Jia-Xin%22">Lin, Jia-Xin</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gan%2C+Bin%22">Gan, Bin</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Xu-Chao%22">Zhang, Xu-Chao</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Hua-Jun%22">Chen, Hua-Jun</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Bin-Chao%22">Wang, Bin-Chao</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tu%2C+Hai-Yan%22">Tu, Hai-Yan</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yang%2C+Jin-Ji%22">Yang, Jin-Ji</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhong%2C+Wen-Zhao%22">Zhong, Wen-Zhao</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Yangqiu%22">Li, Yangqiu</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<i> yangqiuli@hotmail.com</i><br /><searchLink fieldCode="AR" term="%22Zhou%2C+Qing%22">Zhou, Qing</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> gzzhouqing@126.com</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Science+Bulletin%22">Science Bulletin</searchLink>. Feb2024, Vol. 69 Issue 4, p535-543. 9p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=175240970 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.scib.2023.12.046 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 9 StartPage: 535 Titles: – TitleFull: PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Maggie Liu, Si-Yang – PersonEntity: Name: NameFull: Huang, Jie – PersonEntity: Name: NameFull: Deng, Jia-Yi – PersonEntity: Name: NameFull: Xu, Chong-Rui – PersonEntity: Name: NameFull: Yan, Hong-Hong – PersonEntity: Name: NameFull: Yang, Ming-Yi – PersonEntity: Name: NameFull: Li, Yang-Si – PersonEntity: Name: NameFull: Ke, E-E – PersonEntity: Name: NameFull: Zheng, Ming-Ying – PersonEntity: Name: NameFull: Wang, Zhen – PersonEntity: Name: NameFull: Lin, Jia-Xin – PersonEntity: Name: NameFull: Gan, Bin – PersonEntity: Name: NameFull: Zhang, Xu-Chao – PersonEntity: Name: NameFull: Chen, Hua-Jun – PersonEntity: Name: NameFull: Wang, Bin-Chao – PersonEntity: Name: NameFull: Tu, Hai-Yan – PersonEntity: Name: NameFull: Yang, Jin-Ji – PersonEntity: Name: NameFull: Zhong, Wen-Zhao – PersonEntity: Name: NameFull: Li, Yangqiu – PersonEntity: Name: NameFull: Zhou, Qing IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 02 Text: Feb2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 20959273 Numbering: – Type: volume Value: 69 – Type: issue Value: 4 Titles: – TitleFull: Science Bulletin Type: main |
| ResultId | 1 |